Qatar Investment Authority in Autolus Therapeutics plc
Completed. First disclosed December 13, 2022, in a Schedule 13G (source).
- Investor
- Qatar Investment Authority (Qatar)
- Target
- Autolus Therapeutics plc (EDGAR CIK 1730463)
- Target country
- United Kingdom
- Sector
- Health and Life Sciences (SIC 2836)
- First disclosed
- December 13, 2022, Schedule 13G
- Amount
- Not stated
- Stake at first disclosure
- 9.03%
- Latest stated stake
- 9.03% (December 13, 2022)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| December 13, 2022 | Schedule 13G | 9.03% | View |
Cite: Middle East Forum, “Qatar Investment Authority in Autolus Therapeutics plc,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/qia-autolus-therapeutics-plc-1730463/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.